<!-- wp:html --><p>In 2021, a group of scientists led by researchers at the University of North Carolina at Chapel Hill, Weill Cornell Medicine and NewYork-Presbyterian reported that the Moderna mRNA vaccine and a protein-based vaccine candidate containing an adjuvant, a substance that enhances immune responses, elicited durable neutralizing antibody responses to SARS-CoV-2 during infancy in pre-clinical research.</p>
<p>The post <a href="https://whatsnew2day.com/experimental-covid-19-vaccine-offers-long-term-protection-against-severe-disease/">Experimental COVID-19 vaccine offers long-term protection against severe disease</a> appeared first on <a href="https://whatsnew2day.com/">WhatsNew2Day</a>.</p><!-- /wp:html -->
In 2021, a group of scientists led by researchers at the University of North Carolina at Chapel Hill, Weill Cornell Medicine and NewYork-Presbyterian reported that the Moderna mRNA vaccine and a protein-based vaccine candidate containing an adjuvant, a substance that enhances immune responses, elicited durable neutralizing antibody responses to SARS-CoV-2 during infancy in pre-clinical research.
